Dahlia Sano, Nancy Bartlett, Elizabeth Budde, Brett Brinker, Rakhee Vaidya, Sunil Babu, Catherine Diefenbach, Chijioke Nze, Connie Ma, Andrea Knapp, Michelle Doral, Vivian Chen, Paloma Hauser, Michael C. Wei, Pretibha Moorthy, Anna Phillips, Natalie Surh, Adam Jan, Enkhtsetseg Purev, Nina Wagner-Johnston. "Promising response rates and manageable safety with mosunetuzumab plus lenalidomide (Mosun-Len) in patients with relapsed/refractory (R/R) follicular lymphoma (FL): US extension cohort from the Phase III CELESTIMO study." Blood, 2025. doi:10.1182/blood-2025-1800